These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 1948253)
1. Endogenous tumor necrosis factor-alpha in patients with nasopharyngeal carcinoma. Yadav M Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):123-6. PubMed ID: 1948253 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma. Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107 [TBL] [Abstract][Full Text] [Related]
3. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis]. Li D; Li G; Wang B Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763 [TBL] [Abstract][Full Text] [Related]
4. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis. Robak T; Gladalska A; Stepień H Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer. Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341 [TBL] [Abstract][Full Text] [Related]
6. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891 [TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha levels in serum and cerebrospinal fluid of patients with AIDS. Franciotta DM; Melzi d'Eril GL; Bono G; Brustia R; Ruberto G; Pagani I Funct Neurol; 1992; 7(1):35-8. PubMed ID: 1582576 [TBL] [Abstract][Full Text] [Related]
8. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity. Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317 [TBL] [Abstract][Full Text] [Related]
9. Estimation of tumor necrosis factor-alpha in the diagnosis, the prognosis and the treatment follow-up of oral squamous cell carcinoma. Kurokawa H; Yamashita M; Yamashita Y; Murata T; Miura K; Kajiyama M Fukuoka Igaku Zasshi; 1998 Nov; 89(11):312-20. PubMed ID: 9884462 [TBL] [Abstract][Full Text] [Related]
10. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients. Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621 [TBL] [Abstract][Full Text] [Related]
12. [Influence of tumor-associated macrophages on progression and prognosis of nasopharyngeal carcinoma]. Peng J; Ding T; Zheng LM; Shao JY Ai Zheng; 2006 Nov; 25(11):1340-5. PubMed ID: 17094898 [TBL] [Abstract][Full Text] [Related]
13. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients. Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379 [TBL] [Abstract][Full Text] [Related]
14. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA; El-Gendi HI; Ahmed HH Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of elevated serum sICAM-1 in patients with nasopharyngeal carcinoma]. Wang L; Shu M; Wei Q Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 35(6):469-71. PubMed ID: 12768764 [TBL] [Abstract][Full Text] [Related]
16. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease]. Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824 [TBL] [Abstract][Full Text] [Related]
17. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2). Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704 [TBL] [Abstract][Full Text] [Related]
18. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma. Su TR; Chang KL; Lee CH; Chen CH; Yang YH; Shieh TY Oral Oncol; 2004 Sep; 40(8):804-10. PubMed ID: 15288835 [TBL] [Abstract][Full Text] [Related]
19. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients. Pisa P; Stenke L; Bernell P; Hansson M; Hast R Anticancer Res; 1990; 10(3):817-20. PubMed ID: 2114819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]